Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| DMAE (Dimethylaminoethanol) | Pramiracetam | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 150-400 mg/day (as DMAE bitartrate, typically 37% DMAE) | 400-1200 mg/day divided into 2-3 doses |
| Timing | Morning. With or without food. | With fat-containing meals (fat-soluble). Morning and early afternoon dosing preferred. |
| Cycle Duration | Ongoing; no strict cycling required | Cycles of 8-12 weeks on, 4 weeks off |
| Evidence Level | animal_plus_anecdotal | moderate_human |
Structural analog of choline that crosses the BBB more readily than choline itself. Paradoxically increases choline availability not by serving as a direct precursor to acetylcholine, but by inhibiting choline metabolism in peripheral tissues, thereby increasing circulating choline available for brain uptake. Also acts as a free radical scavenger and membrane stabilizer. Reduces lipofuscin accumulation in neuronal cells, an age pigment associated with cellular aging.
150-400 mg/day (as DMAE bitartrate, typically 37% DMAE)
Morning. With or without food.
Ongoing; no strict cycling required
Potently stimulates high-affinity choline uptake (HACU) in hippocampal synaptosomes, the rate-limiting step in acetylcholine synthesis. This profoundly enhances cholinergic neurotransmission without direct receptor agonism. Approximately 10-30x more potent than piracetam on a per-milligram basis. Does not significantly affect other neurotransmitter systems, making it a highly targeted cholinergic enhancer.
400-1200 mg/day divided into 2-3 doses
With fat-containing meals (fat-soluble). Morning and early afternoon dosing preferred.
Cycles of 8-12 weeks on, 4 weeks off
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →